|
|
(PQ1) Molecular circuit of multi-ciliogenesis regulates choroid plexus differentiation and tumor development
|
1R01CA220551-01
|
$383,749
|
$383,749
|
ZHAO, HAOTIAN
|
SANFORD RESEARCH/USD
|
|
|
(PQ3) Modulation of Osteosarcoma Biology by Inflammation and Immunity Defined through a ComparativeApproach
|
5R21CA208529-02
|
$166,388
|
$166,388
|
MODIANO, JAIME
|
UNIVERSITY OF MINNESOTA
|
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
1R21CA217137-01
|
$209,093
|
$209,093
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu
|
5R01CA185039-04
|
$373,436
|
$373,436
|
JAN, LILY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors
|
5R01CA194473-03
|
$347,361
|
$347,361
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
(PQB-2) "Driver" vs. "passenger" epigenetic events in Ewing sarcoma
|
5R01CA183776-05
|
$309,175
|
$309,175
|
LESSNICK, STEPHEN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
5R01CA185402-04
|
$318,923
|
$318,923
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$68,874
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
|
A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma
|
1R01CA204093-01A1
|
$392,078
|
$392,078
|
PANDIT-TASKAR, NEETA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
5R33CA202900-02
|
$412,553
|
$412,553
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling
|
5R01CA181231-02
|
$362,569
|
$181,285
|
REITER, JEREMY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia
|
5R01CA190843-03
|
$311,458
|
$155,729
|
SOHN, LYDIA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
|
A longitudinal assessment of frailty in young adult survivors of childhood cancer
|
5R01CA174851-04
|
$538,152
|
$538,152
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
A Mechanistic Understanding of Neuronal Activity Promotion of High-Grade Glioma Growth through Activity-Regulated Secretion of Neuroligin-3
|
5F31CA200273-03
|
$44,044
|
$11,011
|
VENKATESH, HUMSA
|
STANFORD UNIVERSITY
|
|
|
A Novel Mobile Health Fitness Program for AYA Childhood Cancer Survivors
|
5K07CA174728-04
|
$164,851
|
$164,851
|
DEVINE, KATIE
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
|
A novel oncogenic driver in Ewing sarcoma
|
5R21CA202485-02
|
$165,844
|
$165,844
|
SHIIO, YUZURU
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
1R21CA205106-01A1
|
$234,992
|
$234,992
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors
|
5K07CA178100-05
|
$129,957
|
$129,957
|
HOCKING, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
A role for notch in self renewal in embryonal rhabdomyosarcoma
|
4R00CA175184-03
|
$249,000
|
$249,000
|
IGNATIUS, MYRON
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S1
|
$125,000
|
$17,500
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S2
|
$62,491
|
$8,749
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
$1,093,434
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
ABT-199 based therapies to treat neuroblastoma
|
1R01CA215610-01
|
$371,856
|
$371,856
|
FABER, ANTHONY
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$380,330
|
$190,165
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment
|
7R01CA201444-02
|
$396,181
|
$396,181
|
MITTELMAN, STEVEN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,629,581
|
$48,887
|
Rosenberg, Steven
|
CCR (NCI)
|
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$776,399
|
$776,399
|
Fry, Terry
|
CCR (NCI)
|
|
|
Advancing Treatments for Pediatric Craniopharyngioma (ATPC): Preliminary Assessment of the Cyst Fluid Inflammatory Milieu
|
1R03CA212800-01
|
$77,750
|
$77,750
|
HANKINSON, TODD
|
UNIVERSITY OF COLORADO DENVER
|
|
|
ALL immunobiology and the bone marrow niche
|
ZIA BC 011295
|
$332,742
|
$332,742
|
Fry, Terry
|
CCR (NCI)
|
|
|
Altered mitochondria-ER signaling as a cause of chemotherapy resistance
|
5R21CA198430-02
|
$215,064
|
$215,064
|
HOGARTY, MICHAEL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$109,446
|
Barr, Frederic
|
CCR (NCI)
|
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID
|
ZIA SC 004020
|
$2,592,300
|
$51,846
|
Berzofsky, Jay
|
CCR (NCI)
|
|
|
APPLYING ERROR-CORRECTED SEQUENCING TO DETECT MINIMAL RESIDUAL IN THE AAML 1031 STUDY
|
1R01CA211711-01
|
$388,615
|
$388,615
|
DRULEY, TODD
|
WASHINGTON UNIVERSITY
|
|
|
ARID5B and disparities of childhood leukemia
|
3U01CA176063-04S1
|
$99,290
|
$99,290
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
ARID5B and disparities of childhood leukemia
|
5U01CA176063-04
|
$368,510
|
$368,510
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Assay Development for NSD1 Methyltransferase Inhibitor Discovery
|
5R01CA191077-03
|
$312,244
|
$312,244
|
KOLB, EDWARD
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
|
ATR: a novel therapeutic target for medulloblastoma identified by its role in cerebellar development
|
5F30CA192832-03
|
$34,282
|
$34,282
|
LANG, PATRICK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
Balancing Efficacy and Toxicity of Intratumoral Reolysin for Diffuse Intrinsic Pontine Glioma (DIPG)
|
5F30CA210334-02
|
$44,244
|
$44,244
|
SCHUELKE, MATTHEW
|
MAYO CLINIC ROCHESTER
|
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-04
|
$690,000
|
$172,500
|
BAILEY, LISA
|
BAY AREA TUMOR INSTITUTE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$23,667
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$23,775
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$24,450
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$50,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$650,624
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Bench to bedside: non-invasive treatment of tumors in children
|
1U01CA202947-01A1
|
$350,585
|
$350,585
|
KIM, PETER
|
CHILDREN'S RESEARCH INSTITUTE
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
$37,792
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Bioinformatics: Systems Biology of Pediatric Cancers
|
ZIA BC 011002
|
$340,770
|
$340,770
|
Khan, Javed
|
CCR (NCI)
|
|
|
Biologic and Preclinical Studies of Myeloid Malignancies
|
5R50CA211452-02
|
$146,069
|
$73,035
|
WONG, JASMINE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Biologic for the Treatment of High Risk B Cell Acute Lymphoblastic Leukemia
|
1R43CA224723-01
|
$299,999
|
$299,999
|
Meng, Xianmei
|
ELF ZONE, INC.
|
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$474,811
|
$474,811
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Total relevant funding to Childhood Cancers for this search: $220,273,687
|
